Your browser doesn't support javascript.
loading
Calcium and phosphate levels after kidney transplantation and long-term patient and allograft survival.
Chevarria, Julio; Sexton, Donal J; Murray, Susan L; Adeel, Chaudhry E; O'Kelly, Patrick; Williams, Yvonne E; O'Seaghdha, Conall M; Little, Dilly M; Conlon, Peter J.
Afiliação
  • Chevarria J; Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
  • Sexton DJ; Department of Nephrology, Trinity College Dublin, Dublin, Ireland.
  • Murray SL; Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
  • Adeel CE; Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
  • O'Kelly P; Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
  • Williams YE; Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
  • O'Seaghdha CM; Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
  • Little DM; Department of Urology and Transplant, Beaumont Hospital, Dublin, Ireland.
  • Conlon PJ; Department of Nephrology and Transplantation, Beaumont Hospital, Dublin, Ireland.
Clin Kidney J ; 14(4): 1106-1113, 2021 Apr.
Article em En | MEDLINE | ID: mdl-33841855
ABSTRACT

BACKGROUND:

Non-traditional cardiovascular risk factors, including calcium and phosphate derangement, may play a role in mortality in renal transplant. The data regarding this effect are conflicting. Our aim was to assess the impact of calcium and phosphate derangements in the first 90 days post-transplant on allograft and recipient outcomes.

METHODS:

We performed a retrospective cohort review of all-adult, first renal transplants in the Republic of Ireland between 1999 and 2015. We divided patients into tertiles based on serum phosphate and calcium levels post-transplant. We assessed their effect on death-censored graft survival and all-cause mortality. We used Stata for statistical analysis and did survival analysis and spline curves to assess the association.

RESULTS:

We included 1525 renal transplant recipients. Of the total, 86.3% had hypophosphataemia and 36.1% hypercalcaemia. Patients in the lowest phosphate tertile were younger, more likely female, had lower weight, more time on dialysis, received a kidney from a younger donor, had less delayed graft function and better transplant function compared with other tertiles. Patients in the highest calcium tertile were younger, more likely male, had higher body mass index, more time on dialysis and better transplant function. Adjusting for differences between groups, we were unable to show any difference in death-censored graft failure [phosphate = 1.14, 95% confidence interval (CI) 0.92-1.41; calcium = 0.98, 95% CI 0.80-1.20] or all-cause mortality (phosphate = 1.10, 95% CI 0.91-1.32; calcium = 0.96, 95% CI 0.81-1.13) based on tertiles of calcium or phosphate in the initial 90 days.

CONCLUSIONS:

Hypophosphataemia and hypercalcaemia are common occurrences post-kidney transplant. We have identified different risk factors for these metabolic derangements. The calcium and phosphate levels exhibit no independent association with death-censored graft failure and mortality.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Clin Kidney J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irlanda

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Clin Kidney J Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Irlanda
...